(PACS) PACS - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US69380Q1076
PACS EPS (Earnings per Share)
PACS Revenue
PACS: Skilled Nursing, Assisted Living, Senior Care, Health Properties
PACS Group, Inc. is a leading operator of skilled nursing facilities and assisted living facilities across the United States, providing a range of senior care services. The companys business model is diversified across various healthcare-related properties, including acquisition, ownership, and leasing, positioning it for growth in the aging population segment.
With a foundation established in 2013 and headquartered in Farmington, Utah, PACS Group has been expanding its footprint in the healthcare sector. The companys website (https://pacs.com) provides additional insights into its services and operations. As a publicly traded company listed on the NYSE under the ticker symbol PACS, it is classified under the GICS Sub Industry of Health Care Facilities.
Analyzing the available data, PACS Groups stock has shown significant volatility, with its current price hovering around $10.32. The stocks moving averages indicate a potential bullish trend, with the 20-day SMA at $10.25 and the 50-day SMA at $9.95, suggesting a short-term uptrend. However, the 200-day SMA at $19.50 indicates a longer-term downtrend. The Average True Range (ATR) of 0.44, representing a 4.23% daily price movement, highlights the stocks volatility.
From a fundamental perspective, PACS Group has a market capitalization of approximately $1.54 billion, with a price-to-earnings ratio of 16.26 and a forward P/E of 5.22. The absence of Return on Equity (RoE) data may indicate either a lack of profitability or insufficient data. Considering the companys operational focus and growth prospects, a potential forecast could involve a stabilization of the stock price in the short term, potentially around the $10-$12 range, as the company continues to expand its operations and improve profitability.
Using both technical and fundamental data, a potential forecast for PACS Group could involve a gradual recovery in the stock price as the company leverages its diversified business model and growth opportunities in the senior care sector. If the company can demonstrate improved profitability and stabilize its financial performance, the stock could potentially see a reversion towards its 52-week high, albeit with significant volatility. A key level to watch would be a sustained move above the 20-day SMA, potentially paving the way for further upside. However, the long-term downtrend indicated by the 200-day SMA suggests that a sustained recovery may require more fundamental improvements in the companys financials and operational performance.
Additional Sources for PACS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
PACS Stock Overview
Market Cap in USD | 1,574m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception | 2024-04-11 |
PACS Stock Ratings
Growth Rating | -53.4 |
Fundamental | 40.9 |
Dividend Rating | 0.0 |
Rel. Strength | -51.1 |
Analysts | 4.75 of 5 |
Fair Price Momentum | 10.34 USD |
Fair Price DCF | 15.05 USD |
PACS Dividends
Currently no dividends paidPACS Growth Ratios
Growth Correlation 3m | 20.1% |
Growth Correlation 12m | -86.3% |
Growth Correlation 5y | -76.1% |
CAGR 5y | -37.34% |
CAGR/Max DD 5y | -0.47 |
Sharpe Ratio 12m | -0.36 |
Alpha | -62.25 |
Beta | 0.513 |
Volatility | 105.74% |
Current Volume | 1090.3k |
Average Volume 20d | 361.5k |
As of June 23, 2025, the stock is trading at USD 13.18 with a total of 1,090,253 shares traded.
Over the past week, the price has changed by +29.98%, over one month by +34.49%, over three months by +10.48% and over the past year by -55.40%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, PACS (NYSE:PACS) is currently (June 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 40.88 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PACS is around 10.34 USD . This means that PACS is currently overvalued and has a potential downside of -21.55%.
PACS has received a consensus analysts rating of 4.75. Therefor, it is recommend to buy PACS.
- Strong Buy: 3
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, PACS PACS will be worth about 11.2 in June 2026. The stock is currently trading at 13.18. This means that the stock has a potential downside of -14.95%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 35.5 | 169.3% |
Analysts Target Price | 35.5 | 169.3% |
ValueRay Target Price | 11.2 | -14.9% |